• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ataxin-2中多聚谷氨酰胺重复序列的扩增改变了其高尔基体定位,破坏了高尔基体复合物并导致细胞死亡。

Expansion of the polyQ repeat in ataxin-2 alters its Golgi localization, disrupts the Golgi complex and causes cell death.

作者信息

Huynh Duong P, Yang Hai-Tao, Vakharia Hema, Nguyen Dung, Pulst Stefan M

机构信息

Rose Moss Laboratory for Parkinson and Neurodegenerative Diseases, Burns and Allen Research Institute,UCLA School of Medicine, Los Angeles, California, USA.

出版信息

Hum Mol Genet. 2003 Jul 1;12(13):1485-96. doi: 10.1093/hmg/ddg175.

DOI:10.1093/hmg/ddg175
PMID:12812977
Abstract

Spinocerebellar ataxia type 2 (SCA2) is caused by the expansion of a polyglutamine (polyQ) repeat in ataxin-2, the SCA2 gene product. In contrast to other polyQ diseases, intranuclear inclusions are not prominent in SCA2. In animal models with expression of mutant ataxin-2 targeted to Purkinje cells, neuronal dysfunction and morphologic changes are observed without the formation of intranuclear aggregates. In this report, we investigated the mechanisms underlying SCA2 pathogenesis using cellular models. We confirmed that the SCA2 gene product, ataxin-2, was predominantly located in the Golgi apparatus. Deletion of ER-exit and trans-Golgi signals in ataxin-2 resulted in an altered subcellular distribution. Expression of full-length ataxin-2 with an expanded repeat disrupted the normal morphology of the Golgi complex and colocalization with Golgi markers was lost. Intranuclear inclusions were only seen when the polyQ repeat was expanded to 104 glutamines, and even then were only observed in a small minority of cells. Expression of ataxin-2 with expanded repeats in PC12 and COS1 cells increased cell death compared with normal ataxin-2 and elevated the levels of activated caspase-3 and TUNEL-positive cells. These results suggest a link between cell death mediated by mutant ataxin-2 and the stability of the Golgi complex. The formation of intranuclear aggregates is not necessary for in vitro cell death caused by expression of full-length mutant ataxin-2.

摘要

2型脊髓小脑共济失调(SCA2)由SCA2基因产物ataxin-2中的多聚谷氨酰胺(polyQ)重复序列扩增引起。与其他多聚谷氨酰胺疾病不同,SCA2中核内包涵体并不突出。在将突变型ataxin-2表达靶向浦肯野细胞的动物模型中,观察到神经元功能障碍和形态学变化,但未形成核内聚集体。在本报告中,我们使用细胞模型研究了SCA2发病机制的潜在机制。我们证实,SCA2基因产物ataxin-2主要位于高尔基体。ataxin-2中内质网出口和反式高尔基体信号的缺失导致亚细胞分布改变。具有扩增重复序列的全长ataxin-2的表达破坏了高尔基体复合体的正常形态,并且与高尔基体标记物的共定位丧失。仅当多聚谷氨酰胺重复序列扩增至104个谷氨酰胺时才可见核内包涵体,即便如此,也仅在少数细胞中观察到。与正常ataxin-2相比,在PC12和COS1细胞中表达具有扩增重复序列的ataxin-2会增加细胞死亡,并提高活化的半胱天冬酶-3水平和TUNEL阳性细胞数量。这些结果表明,突变型ataxin-2介导的细胞死亡与高尔基体复合体的稳定性之间存在联系。全长突变型ataxin-2表达引起的体外细胞死亡并不需要形成核内聚集体。

相似文献

1
Expansion of the polyQ repeat in ataxin-2 alters its Golgi localization, disrupts the Golgi complex and causes cell death.ataxin-2中多聚谷氨酰胺重复序列的扩增改变了其高尔基体定位,破坏了高尔基体复合物并导致细胞死亡。
Hum Mol Genet. 2003 Jul 1;12(13):1485-96. doi: 10.1093/hmg/ddg175.
2
Ataxin-2 mediated cell death is dependent on domains downstream of the polyQ repeat.ataxin-2介导的细胞死亡依赖于多聚谷氨酰胺重复序列下游的结构域。
Exp Neurol. 2007 Dec;208(2):207-15. doi: 10.1016/j.expneurol.2007.07.023. Epub 2007 Aug 28.
3
Parkin is an E3 ubiquitin-ligase for normal and mutant ataxin-2 and prevents ataxin-2-induced cell death.帕金蛋白是正常和突变型ataxin-2的E3泛素连接酶,并可防止ataxin-2诱导的细胞死亡。
Exp Neurol. 2007 Feb;203(2):531-41. doi: 10.1016/j.expneurol.2006.09.009. Epub 2006 Nov 9.
4
Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human.ataxin-2的核定位或包涵体形成对于小鼠或人类的脊髓小脑共济失调2型(SCA2)发病机制并非必需。
Nat Genet. 2000 Sep;26(1):44-50. doi: 10.1038/79162.
5
Ataxin-2 interacts with FUS and intermediate-length polyglutamine expansions enhance FUS-related pathology in amyotrophic lateral sclerosis.共济失调蛋白 2 与 FUS 相互作用,并且中间长度的聚谷氨酰胺扩展增强了肌萎缩侧索硬化症中的 FUS 相关病理学。
Hum Mol Genet. 2013 Feb 15;22(4):717-28. doi: 10.1093/hmg/dds479. Epub 2012 Nov 19.
6
The role of protein composition in specifying nuclear inclusion formation in polyglutamine disease.蛋白质组成在多聚谷氨酰胺疾病中决定核内包涵体形成的作用。
J Biol Chem. 2001 Nov 30;276(48):44889-97. doi: 10.1074/jbc.M106575200. Epub 2001 Sep 25.
7
Progress in pathogenesis studies of spinocerebellar ataxia type 1.1型脊髓小脑共济失调发病机制研究进展
Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1079-81. doi: 10.1098/rstb.1999.0462.
8
Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias--triple-labeling immunofluorescence study.遗传性共济失调核内包涵体中的非扩展型聚谷氨酰胺蛋白——三重标记免疫荧光研究
Acta Neuropathol. 2001 Aug;102(2):149-52. doi: 10.1007/s004010100364.
9
Ataxin-1 fusion partners alter polyQ lethality and aggregation.ataxin-1融合伴侣改变多聚谷氨酰胺的致死性和聚集性。
PLoS One. 2007 Oct 10;2(10):e1014. doi: 10.1371/journal.pone.0001014.
10
Amino acid sequences flanking polyglutamine stretches influence their potential for aggregate formation.多聚谷氨酰胺延伸段两侧的氨基酸序列会影响其形成聚集体的可能性。
Neuroreport. 2001 Oct 29;12(15):3357-64. doi: 10.1097/00001756-200110290-00042.

引用本文的文献

1
Decoding ATXN2 Phosphocode: Structural Insights and Therapeutic Opportunities in Disease.解码共济失调蛋白2磷酸密码:疾病中的结构见解与治疗机会
Protein J. 2025 Aug 30. doi: 10.1007/s10930-025-10287-4.
2
The LSmAD Domain of Ataxin-2 Modulates the Structure and RNA Binding of Its Preceding LSm Domain.Ataxin-2的LSmAD结构域调节其上游LSm结构域的结构和RNA结合。
Cells. 2025 Mar 6;14(5):383. doi: 10.3390/cells14050383.
3
The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease.多聚谷氨酰胺蛋白 ATXN2:从其分子功能到其在疾病中的作用。
Cell Death Dis. 2024 Jun 14;15(6):415. doi: 10.1038/s41419-024-06812-5.
4
Split but merge: Golgi fragmentation in physiological and pathological conditions.分裂又融合:生理和病理条件下的高尔基复合体碎片化。
Mol Biol Rep. 2024 Jan 27;51(1):214. doi: 10.1007/s11033-023-09153-2.
5
The stress granule protein G3BP1 alleviates spinocerebellar ataxia-associated deficits.应激颗粒蛋白 G3BP1 可减轻脊髓小脑共济失调相关缺陷。
Brain. 2023 Jun 1;146(6):2346-2363. doi: 10.1093/brain/awac473.
6
Ubiquitin-specific peptidase 10, a deubiquitinating enzyme: Assessing its role in tumor prognosis and immune response.泛素特异性肽酶10,一种去泛素化酶:评估其在肿瘤预后和免疫反应中的作用。
Front Oncol. 2022 Sep 28;12:990195. doi: 10.3389/fonc.2022.990195. eCollection 2022.
7
A survey of protein interactions and posttranslational modifications that influence the polyglutamine diseases.一项关于影响多聚谷氨酰胺疾病的蛋白质相互作用和翻译后修饰的调查。
Front Mol Neurosci. 2022 Sep 14;15:974167. doi: 10.3389/fnmol.2022.974167. eCollection 2022.
8
A peptide inhibitor that rescues polyglutamine-induced synaptic defects and cell death through suppressing RNA and protein toxicities.一种通过抑制RNA和蛋白质毒性来挽救多聚谷氨酰胺诱导的突触缺陷和细胞死亡的肽抑制剂。
Mol Ther Nucleic Acids. 2022 Jun 13;29:102-115. doi: 10.1016/j.omtn.2022.06.004. eCollection 2022 Sep 13.
9
Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis.半胱天冬酶-3 在调节细胞存活、增殖和肿瘤发生中的矛盾作用。
J Cell Biol. 2022 Jun 6;221(6). doi: 10.1083/jcb.202201159. Epub 2022 May 12.
10
Characterization of RAN Translation and Antisense Transcription in Primary Cell Cultures of Patients with Myotonic Dystrophy Type 1.1型强直性肌营养不良患者原代细胞培养物中RAN翻译和反义转录的特征分析
J Clin Med. 2021 Nov 25;10(23):5520. doi: 10.3390/jcm10235520.